Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia

NCT00999973 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Myopia

Interventions

DRUG: Mitomycin C 0.02%
DRUG: Placebo

Sponsor

Shahid Beheshti University of Medical Sciences